By The Lucas Project
Marc Engelen is a neurologist at Amsterdam UMC whose work includes children and adults with neurometabolic disorders. His research at the Amsterdam Leukodystrophy Center has a particular focus on adrenoleukodystrophy (ALD) and on measuring how disease changes over time. Amsterdam UMC profile
Specialty and research focus
Natural-history studies follow the course of a condition. Engelen’s work also examines ways to measure disease severity more sensitively, which may help researchers evaluate potential treatments in clinical trials. A change in an imaging or laboratory measure is not automatically proof that a treatment improves daily life. Researchers evaluate whether changes in these measures correspond to benefits in daily life. Amsterdam UMC profile Amsterdam Leukodystrophy Center conference biography
Why measuring ALD progression matters
A treatment study needs a way to judge whether a potential therapy makes a meaningful difference. Engelen’s research addresses this problem through natural-history studies and the development of outcome measures. Natural-history research documents how a condition changes over time and helps establish what a future trial should measure. Amsterdam Leukodystrophy Center biography
An Amsterdam UMC research abstract describes approaches including advanced imaging, balance measurements and biochemical analyses. These methods examine different aspects of disease. A measure that detects change accurately may be useful in research, but researchers still need to establish what that change means for a person’s function and daily life. Research abstract
For readers following adult ALD and adrenomyeloneuropathy, or AMN, this work provides context for news about trial endpoints. An endpoint is the result a trial uses to assess an intervention. The choice of endpoint affects what the study can demonstrate; a favorable result on one measure does not answer every question about long-term benefit.
How to contact the team
An Amsterdam UMC research abstract lists m.engelen@amsterdamumc.nl. This is a professional research contact, not a confirmed appointment-booking address. Ask the hospital about clinical referrals and eligibility for care. Research abstract and contact
How to support the work
No dedicated public donation page for Engelen’s ALD work has been verified. Ask the team for the appropriate institutional giving contact and whether gifts can be restricted to ALD research. Amsterdam UMC profile
Questions about a study or referral
Ask whether an opportunity is an observational study or a treatment trial, what visits and tests it requires, and whether travel is necessary. For clinical care, ask the hospital which service handles adult or pediatric referrals. A research email does not itself establish access to clinical appointments.
Professional contacts and giving designations were checked on November 11, 2026; confirm them with the institution before making arrangements.